CSI Market
Sign In | Register

Gain Therapeutics inc (GANX) Annual Balance Sheets

Annual · GAAP · USD millions
Access GANX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Gain Therapeutics inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GANX/balance-sheets
https://api.csimarket.com/api/v1/companies/GANX/fundamentals
https://api.csimarket.com/api/v1/companies/GANX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent20.84
Marketable Securities, Current SH0.00
Cash & Short-term Investments20.00
Other Current Assets0.18
Prepaid Expense And Other Assets Current1.22
Total Current Assets22.24
Equipment/Property/Plant Net0.07
Long-term investments0.00
Other Assets, Noncurrent0.51
Deferred Income Taxes And Other Tax Receivable Current0.18
Operating Lease Right Of Use Asset0.33
Restricted Cash Noncurrent0.04
Total Assets22.82
Liabilities
Accounts Payable, Current AC0.83
Long-term Debt, Current Maturities LO0.10
Other Liabilities, Current2.31
Taxes Payable, Current, Total0.00
Total Current Liabilities3.35
Long-term debt0.30
Total Long-term Debt0.30
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.39
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.12
Deferred Income Current-
Operating Lease Liability Noncurrent0.21
Total Liabilities4.25
Stockholders' Equity
Income Loss For Period-20.16
Common Stock Value0.00
Additional Paid In Capital Common Stock119.14
Retained Earnings / Accumulated Deficit-81.19
Other Equity0.78
Common Stockholder's Equity18.56
Total Stockholder's Equity18.56
Liabilities & Stockholder's Equity22.82
4 historic quarters locked

Sign in to unlock the full Gain Therapeutics inc balance sheet history.

Sign In Create Free Account

About Gain Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-035188

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI